aspiration during anesthesia semaglutide case report 2023 What To Know About After EU Warns Of The Risk From GLP-1 Drugs GLP-1 drugs and aspiration risk

Cell Rep 9:21242138

Key points highlighted in the session included: GLP-1 receptor agonists have been used clinically since 2005, with earlier formulations prescribed at lower doses Newer medications and dosing regimens have increased weight loss outcomes Public familiarity with medications such as Ozempic, Wegovy, Mounjaro, and Zepbound has grown rapidly Increased access and demand have led to broader prescribing patterns and new clinical questions This growth has outpaced many clinicians training around eating disorder risk and weight-inclusive care

Telehealth has revolutionized access to weight loss medications by eliminating geographic barriers, reducing costs, and streamlining the process from consultation to delivery

The saline group demonstrated pronounced enrichment of multiple metabolic and signaling pathwayssuch as PPAR signaling, fatty acid elongation, steroid biosynthesis, and AMPK signalingrelative to the control group

Lifehacks: Research-backed treatments for pancreatitis Basics for people with recurrent acute or chronic pancreatitis: Dont drink alcohol